Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation

    December 2024 in “ Antibiotics
    Lenka Dzurová, Edita Holásková, Hana Pospíšilová, Gabriela Schneider Rauber, Jitka Frébortová
    TLDR Cathelicidins could treat skin issues but face challenges like safety and resistance.
    Cathelicidins, particularly LL-37, are promising antimicrobial peptides for treating skin conditions like melanoma, acne, and diabetic foot ulcers due to their broad-spectrum antimicrobial and immunomodulatory activities. However, their clinical application faces challenges such as high production costs, susceptibility to protease degradation, microbial resistance, and safety concerns like potential mutagenicity. Strategies to overcome these include improving peptide formulation, using advanced drug delivery systems, and exploring plant-based production. Despite promising results in clinical trials, further research is needed to address these challenges and fully realize the therapeutic potential of cathelicidins in dermatology.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    1 / 1 results

    Similar Research

    5 / 191 results